Total Payments
$6,030
2024 Payments
$1,757
Companies
67
Transactions
358
Medicare Patients
6,848
Medicare Billing
$3.4M
Payment Breakdown by Category
Food & Beverage$5,723 (94.9%)
Other$200.00 (3.3%)
Education$106.93 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,723 | 350 | 94.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $200.00 | 1 | 3.3% |
| Education | $106.93 | 7 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $600.88 | 38 | $0 (2024) |
| Merck Sharp & Dohme LLC | $539.75 | 34 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $309.02 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $302.70 | 22 | $0 (2024) |
| Incyte Corporation | $286.06 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $252.13 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $243.00 | 13 | $0 (2024) |
| Genentech USA, Inc. | $239.87 | 20 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $219.58 | 15 | $0 (2024) |
| Amgen Inc. | $218.75 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,757 | 91 | Novartis Pharmaceuticals Corporation ($205.24) |
| 2023 | $1,167 | 63 | Seagen Inc. ($92.69) |
| 2022 | $27.21 | 2 | Myovant Sciences Inc. ($14.24) |
| 2021 | $14.00 | 1 | Accuray Incorporated ($14.00) |
| 2020 | $229.02 | 14 | E.R. Squibb & Sons, L.L.C. ($58.07) |
| 2019 | $974.25 | 67 | Merck Sharp & Dohme Corporation ($142.08) |
| 2018 | $1,101 | 63 | Medtronic Vascular, Inc. ($200.00) |
| 2017 | $760.56 | 57 | Novartis Pharmaceuticals Corporation ($123.50) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $32.80 | General |
| Category: Oncology | ||||||
| 12/19/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $21.98 | General |
| Category: Oncology | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ONCOLOGY | ||||||
| 12/16/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $15.73 | General |
| Category: Oncology / Rare Diseases | ||||||
| 12/14/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Oncology | ||||||
| 12/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $9.95 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $2.72 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $0.37 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $24.99 | General |
| Category: Hematology/Oncology | ||||||
| 12/09/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: ONCOLOGY | ||||||
| 12/04/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $32.01 | General |
| 11/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), WELIREG, LYNPARZA | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.72 | General |
| Category: ONCOLOGY | ||||||
| 11/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $0.46 | General |
| Category: ONCOLOGY | ||||||
| 11/14/2024 | SERVIER PHARMACEUTICALS LLC | Tibsovo (Drug) | Food and Beverage | In-kind items and services | $24.38 | General |
| Category: Oncology | ||||||
| 11/13/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Oncology | ||||||
| 11/12/2024 | ABBVIE INC. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: ONCOLOGY | ||||||
| 11/07/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/31/2024 | BeiGene USA, Inc. | TEVIMBRA (Drug) | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Stivarga (Drug), Vitrakvi | Food and Beverage | In-kind items and services | $17.95 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Vyloy (Drug) | Food and Beverage | In-kind items and services | $29.60 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $9.17 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 1,360 | 9,469 | $2.0M | $636,940 |
| 2022 | 37 | 1,615 | 13,554 | $2.3M | $717,699 |
| 2021 | 39 | 2,000 | 14,523 | $3.3M | $1.1M |
| 2020 | 35 | 1,873 | 10,908 | $3.1M | $994,714 |
Total Patients
6,848
Total Services
48,454
Medicare Billing
$3.4M
Procedure Codes
147
All Medicare Procedures & Services
147 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 33 | 740 | $596,440 | $184,791 | 31.0% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 65 | 1,231 | $339,263 | $107,987 | 31.8% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 37 | 535 | $283,015 | $87,567 | 30.9% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 37 | 38 | $156,518 | $49,456 | 31.6% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 44 | 182 | $108,956 | $34,825 | 32.0% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 65 | 226 | $104,588 | $33,438 | 32.0% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 74 | 259 | $49,037 | $15,783 | 32.2% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 47 | 49 | $49,552 | $15,596 | 31.5% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 77 | 164 | $47,044 | $14,877 | 31.6% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 35 | 40 | $42,720 | $13,533 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 147 | $44,693 | $13,302 | 29.8% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 31 | 31 | $34,095 | $10,950 | 32.1% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 73 | 74 | $30,475 | $9,563 | 31.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 126 | 152 | $32,558 | $9,089 | 27.9% |
| 77470 | Special radiation treatment | Office | 2023 | 71 | 72 | $23,728 | $7,575 | 31.9% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 76 | 147 | $22,425 | $7,171 | 32.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 42 | 42 | $22,188 | $6,817 | 30.7% |
| 77370 | Special medical radiation therapy consultation | Office | 2023 | 49 | 69 | $20,959 | $6,746 | 32.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 31 | 31 | $12,373 | $3,711 | 30.0% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 14 | 15 | $4,520 | $1,060 | 23.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 21 | $2,797 | $894.81 | 32.0% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 13 | 14 | $3,682 | $624.50 | 17.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 45 | 5,045 | $2,018 | $598.43 | 29.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 44 | 51 | $1,071 | $420.59 | 39.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 14 | 15 | $390.00 | $155.25 | 39.8% |
About Dr. David Shimm, MD
Dr. David Shimm, MD is a Radiation Oncology healthcare provider based in Beckley, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/04/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770570731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Shimm, MD has received a total of $6,030 in payments from pharmaceutical and medical device companies, with $1,757 received in 2024. These payments were reported across 358 transactions from 67 companies. The most common payment nature is "Food and Beverage" ($5,723).
As a Medicare-enrolled provider, Shimm has provided services to 6,848 Medicare beneficiaries, totaling 48,454 services with total Medicare billing of $3.4M. Data is available for 4 years (2020–2023), covering 147 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Location Beckley, WV
- Active Since 10/04/2005
- Last Updated 07/08/2007
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1770570731
Products in Payments
- KEYTRUDA (Biological) $529.77
- Enhertu (Drug) $252.13
- OPDIVO (Biological) $244.75
- JAKAFI (Drug) $187.80
- LYNPARZA (Drug) $144.37
- KISQALI (Drug) $134.11
- Kyprolis (Biological) $129.53
- Nerlynx (Drug) $125.66
- TASIGNA (Drug) $124.05
- ZEJULA (Drug) $121.38
- FERAHEME (Drug) $106.93
- SARCLISA (Biological) $103.52
- NINLARO (Drug) $102.58
- AFINITOR (Drug) $94.37
- Abraxane (Drug) $81.37
- Stivarga (Drug) $75.56
- IMBRUVICA (Drug) $73.34
- Lonsurf (Drug) $72.63
- GAZYVA (Biological) $72.61
- PLUVICTO (Drug) $72.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.